Balance Sheet
AssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPensionProperty, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Growth Metrics
Income Statement
Others
Ratios

Fresenius Medical Care AG (FMCQF) Liabilities and Shareholders Equity (2016 - 2025)

Fresenius Medical Care AG has reported Liabilities and Shareholders Equity over the past 17 years, most recently at $36.1 billion for Q4 2025.

  • Quarterly results put Liabilities and Shareholders Equity at $36.1 billion for Q4 2025, up 0.61% from a year ago — trailing twelve months through Dec 2025 was $108.5 billion (up 49.71% YoY), and the annual figure for FY2025 was $36.1 billion, up 0.61%.
  • Liabilities and Shareholders Equity for Q4 2025 was $36.1 billion at Fresenius Medical Care AG, up from $35.9 billion in the prior quarter.
  • Over the last five years, Liabilities and Shareholders Equity for FMCQF hit a ceiling of $36.5 billion in Q4 2023 and a floor of $43.7 million in Q4 2022.
  • Median Liabilities and Shareholders Equity over the past 5 years was $35.9 billion (2024), compared with a mean of $21.7 billion.
  • Biggest five-year swings in Liabilities and Shareholders Equity: crashed 74.21% in 2021 and later surged 83516.35% in 2023.
  • Fresenius Medical Care AG's Liabilities and Shareholders Equity stood at $58.0 million in 2021, then decreased by 24.69% to $43.7 million in 2022, then surged by 83516.35% to $36.5 billion in 2023, then fell by 1.75% to $35.9 billion in 2024, then increased by 0.61% to $36.1 billion in 2025.
  • The last three reported values for Liabilities and Shareholders Equity were $36.1 billion (Q4 2025), $35.9 billion (Q4 2024), and $36.5 billion (Q4 2023) per Business Quant data.